Device Helps Protect Cereals by Diagnosing Herbicide Resistance in Weeds By Alexander Burik 2 minutesmins June 14, 2018 -Updated: onJune 24, 2022 2 minutesmins Share WhatsApp Twitter Linkedin Email Newsletter Signup - Under Article / In Page"*" indicates required fieldsCommentsThis field is for validation purposes and should be left unchanged.Subscribe to our newsletter to get the latest biotech news!By clicking this I agree to receive Labiotech's newsletter and understand that my personal data will be processed according to the Privacy Policy.*Company name*Job title*Business email* Mologic and Newcastle University have launched a diagnostic device that provides rapid information on herbicide resistance for a common weed, which could help cut major losses for the British agricultural industry.The partnership between academia and industry has developed a device that can diagnose herbicide resistance in the blackgrass weed, which could help farmers protect their crops more effectively. The device, called the blackgrass resistance diagnostic (BReD), works by detecting levels of an enzyme that is highly concentrated in blackgrass that makes it resistant to multiple types of herbicides. If the enzyme is present, a red band will appear on the device.Blackgrass is a major problem in the UK due to its resistance to multiple herbicides, causing losses of around €567M (£500M) each year. Current herbicide resistance testing methods need to send seeds or whole plants off-site, which is time-consuming and can produce variable results. BReD can provide results within five minutes, allowing farmers to make instant adjustments to blackgrass control.“As far as we are aware, the only competitive products are traditional seed viability testing, which can take 3-4 weeks to provide a diagnosis, or molecular assay testing, which can be expensive and still take 3-5 days to provide a diagnosis,” Mitch Brooker, General Manager at Mologic, told Labiotech. “BReD provides an immediate diagnosis in the field for a cost effective solution.”“Early-indication diagnostic tests are common place in medicine, such as for pregnancy or diabetes, and are used to help people make decisions much earlier on with the aim of improving the long-term outcome. It should be no different in agriculture,” commented Rob Edwards, Professor of Agriculture at Newcastle University.Interestingly, Paul Davis, co-founder and chief scientific officer of Mologics, was one of the founders of the Clear Blue pregnancy test, a well-known product that has had a major impact on people’s lives. The company has until now solely focused on medical diagnostics and this is their first foray into the agricultural space. Big players are also interested in this space. For example, Bayer’s Weed Resistance Competence Center conducts tests to see if resistance to a particular herbicide exists and better understand herbicide metabolism. Additionally, last year, Kaima Bio Agritech partnered with BASF to find new herbicide resistance traits and weed control methods that could improve crop productivity.Suggested Articles Dutch VC Raises €105M to Nurture European Biotech Startups Gene activity could help identify risk of kidney cancer spreading Roche launches next-generation SARS-CoV-2 Rapid Antibody Test Regen BioPharma files patent on new RNA/DNA-based approach to cancer immunotherapy Janssen looks for talquetamab marketing approval Images by keantian, Fotokostic/Shutterstock Explore other topics: DiagnosticsUnited Kingdom ADVERTISEMENT